PATENT CLAIM ANALYSIS

Application Number: 16169937
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-05
Patent Classification: ["544", "283000"]

Abstract:
Polymorphs of N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4, 5-dihydrooxazol-2-yl)quinazoline-4,6-diamine are provided herein. Processes for preparing the polymorphs and pharmaceutical composition comprising the polymorphs are also disclosed.

Claim (Index 205):
The method of  claim 200 , wherein one or more additional compounds having anti-cancer properties are administered in combination.

Metadata:
- Claim Count in Document: 39.0
- Percentile: 97.0
- Lexical Diversity: 1.30303
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14923172', '15861444', '14351835', '14351840', '12933044']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8164524460089699
- 35 USC 102 Novelty (BERT): 0.6326237130826985
- Combined Prediction Score: 0.7980695727163428
- Mean Citation Score: 512.64253
- Max Citation Score: 650.04755
- Similarity Product: 526.1120026966543

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test